Showing results (101-110 of 156) with videos related to

Sort By:
Pageof 16
Cancer Medicine|January 10, 2014
Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancerEriko Tokunaga, Yuichi Hisamatsu, Kenji Taketani, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|February 8, 2022
Long-Term Safety and Effectiveness of PF-05280014 (a Trastuzumab Biosimilar) Treatment in Patients with HER2-Positive Metastatic Breast Cancer: Updated Results of a Randomized, Double-Blind StudyRubi K Li, Eriko Tokunaga, Hryhoriy Adamchuk, et al.
Surgery Today|August 31, 2013
Surgical strategies for esophageal cancer associated with head and neck cancerMasaru Morita, Hiroshi Saeki, Shuhei Ito, et al.
Molecular Cancer Therapeutics|February 22, 2015
Trifluridine Induces p53-Dependent Sustained G2 Phase Arrest with Its Massive Misincorporation into DNA and Few DNA Strand BreaksKazuaki Matsuoka, Makoto Iimori, Shinichiro Niimi, et al.
Surgical Case Reports|August 23, 2024
A case of BIA-ALCL in which postoperative chest wall recurrence was highly suspected: the third reported case of BIA-ALCL in JapanWakako Tajiri, Ryo Shimamoto, Yutaka Koga, et al.
Molecular Cancer Research : MCR|February 28, 2013
Molecular hierarchy of heparin-binding EGF-like growth factor-regulated angiogenesis in triple-negative breast cancerFusanori Yotsumoto, Eriko Tokunaga, Eiji Oki, et al.
Biosensors & Bioelectronics|February 16, 2010
Gold nanoparticle-based colorimetric assay for cancer diagnosisJeong-Hun Kang, Yoji Asami, Masaharu Murata, et al.
The Oncologist|June 15, 2020
Health-Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2- Advanced Breast CancerMatthew P Goetz, Miguel Martin, Eriko Tokunaga, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2016
[The Molecular Aspect of the Antitumor Effect of Oxaliplatin in Combination with 5-FU]Hiroyuki Kitao, Shinichi Kiyonari, Makoto Iimori, et al.
JMIR Research Protocols|February 3, 2026
Optimizing Antiemetic Support in Anthracycline-Based Chemotherapy for Early Breast Cancer: Protocol for a Prospective Observational Study of Four-Drug Antiemetic Therapy Including Fosnetupitant and OlanzapineAyako Higuchi, Yumiko Koi, Tomoaki Eto, et al.
Pageof 16